Literature DB >> 7273240

Cellular and chemical reduction products of misonidazole.

A J Varghese, G F Whitmore.   

Abstract

Misonidazole is readily reduced by zinc dust in aqueous solution in the presence of ammonium chloride. High pressure liquid chromatographic (HPLC) separation of the reduction mixture revealed the presence of three products. These were identified as the hydroxylamine, amine and the hydrazo derivative of misonidazole. There is evidence that the azoxy derivative was an intermediate in the reduction process. When the reduction was carried out in dilute solution (0.1 mg/ml), the hydroxylamine was the only product. In concentrated solution (20 mg/ml), the hydrazo derivative was the major product. When misonidazole was reduced with hydrogen using palladium as catalyst, the amine was the only detectable product. Of the three products, only the hydroxylamine was found to bind covalently to bovine albumin. In Chinese hamster ovary (CHO) cells under hypoxic conditions the amine was confirmed as one of the metabolites. There was no evidence for the presence of detectable amounts of the hydroxylamine in the cell extracts. These studies suggest that the hydroxylamine is probably the reactive reduction metabolite responsible for the in vivo and in vitro binding of misonidazole to cellular macromolecules.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273240     DOI: 10.1016/0009-2797(81)90016-8

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  4 in total

1.  3'-Formyl phosphate-ended DNA: high-energy intermediate in antibiotic-induced DNA sugar damage.

Authors:  D H Chin; L S Kappen; I H Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

2.  Imaging Mass Spectrometry Revealed the Accumulation Characteristics of the 2-Nitroimidazole-Based Agent "Pimonidazole" in Hypoxia.

Authors:  Yukiko Masaki; Yoichi Shimizu; Takeshi Yoshioka; Fei Feng; Songji Zhao; Kenichi Higashino; Yoshito Numata; Yuji Kuge
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

3.  FMISO accumulation in tumor is dependent on glutathione conjugation capacity in addition to hypoxic state.

Authors:  Yukiko Masaki; Yoichi Shimizu; Takeshi Yoshioka; Ken-Ichi Nishijima; Songji Zhao; Kenichi Higashino; Yoshito Numata; Nagara Tamaki; Yuji Kuge
Journal:  Ann Nucl Med       Date:  2017-07-10       Impact factor: 2.668

4.  The accumulation mechanism of the hypoxia imaging probe "FMISO" by imaging mass spectrometry: possible involvement of low-molecular metabolites.

Authors:  Yukiko Masaki; Yoichi Shimizu; Takeshi Yoshioka; Yukari Tanaka; Ken-Ichi Nishijima; Songji Zhao; Kenichi Higashino; Shingo Sakamoto; Yoshito Numata; Yoshitaka Yamaguchi; Nagara Tamaki; Yuji Kuge
Journal:  Sci Rep       Date:  2015-11-19       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.